Marlot van der Wal
6PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 23, 2026
Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.Mick J M van Eijs, M Marlot van der Wal, Hedi-Britt Klotškova
|Nov 18, 2025
Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.Mick J M van Eijs, M Marlot van der Wal, Hedi-Britt Klotškova
|Feb 09, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.Roselie Achten, Judith Thijs, Marlot van der Wal
|Sep 13, 2023
IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval.Coco Dekkers, M Marlot van der Wal, Leonie van den Noort
|Mar 16, 2022
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients.Roselie E Achten, Daphne S Bakker, Chantal M van Luijk
|May 12, 2021
Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation.Gerdien Mijnheer, Lisanne Lutter, Michal Mokry
Pageof 1
Frequent Collaborators
4 joint publications
Femke van Wijk
3 joint publications
Daphne S Bakker
3 joint publications
Marjolein S de Bruin-Weller
2 joint publications
Judith Thijs
2 joint publications
Mick J M van Eijs
2 joint publications
Hedi-Britt Klotškova
2 joint publications
Mark Schuiveling
2 joint publications
Rik J Verheijden
2 joint publications
Karijn P M Suijkerbuijk
2 joint publications
Roselie E Achten
